worldwiki
government证据等级 A独立来源
证据页

FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients

U.S. Food and Drug Administration

发布 2024年12月18日访问于 2026年9月19日更新 2026年9月20日
原始来源

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-remestemcel-l-rknd-steroid-refractory-acute-graft-versus-host-disease-pediatric

fda.gov

核验

核验独立于主体的来源
证据等级A · 政府·监管机构
独立来源与对象无关的独立来源
来源government
链接状态自动链接检查失败（浏览器中可能仍可打开）

官方声明是服务方的陈述,除非另有标注,否则未经 worldwiki 验证。 来源政策

引用页面 (6)

AnswerWhat is the difference between adult stem cells and embryonic stem cells?AnswerWhere are adult stem cells found in the body?AnswerWhat diseases are treated with adult stem cells?AnswerAre mesenchymal stem cell treatments FDA approved?AnswerSVF와 지방유래 줄기세포 차이, 배양 여부와 규제는 어떻게 다른가?ArticleAdult Stem Cell (Somatic Stem Cell): Definition, Types, Established Uses and Evidence